Literature DB >> 16828676

Predictors identified for losses to follow-up among HIV-seropositive patients.

Emilie Lanoy1, Murielle Mary-Krause, Pierre Tattevin, Rosemary Dray-Spira, Claudine Duvivier, Patricia Fischer, Yolande Obadia, France Lert, Dominique Costagliola.   

Abstract

BACKGROUND AND
OBJECTIVE: This study aims to describe predictors of loss to follow-up (LFU) in the French Hospital Database on HIV infection (FHDH).
METHODS: We studied the prevalence and predictors of LFU among 34,835 patients enrolled in FHDH in 1999. Impacts of demographic and clinical factors were studied by using multivariate logistic regression analysis.
RESULTS: Among included patients, 1,478 (4.2%) died and 2,950 (8.5%) were lost to follow-up. LFU was more frequent among recently diagnosed patients (<1 year, 16.8%; > 1 year, 7.1). Among recently diagnosed patients, LFU was less frequent among men who have sex with men (MSM) [odds radio (OR) = 0.6, 95% confidence interval (CI) = (0.5;0.7)], and among patients with AIDS [OR = 0.5, 95%CI = (0.4;0.6)], and more frequent among immigrants [OR = 1.3, 95%CI = (1.0;1.5)]. Among less recently diagnosed patients, LFU was more frequent in French Departments of America than in the Paris area. The proportion of LFU fell with age, and LFU was more frequent among intravenous drug users (IVDU) than among MSM [OR = 1.2, 95%CI = (1.1;1.4)]. Patients with viral load >5,000 copies/mL or CD4 cell counts <200/mm(3) were more likely to be lost to follow-up.
CONCLUSIONS: Recently diagnosed patients, IVDU, and immigrants are more often lost to follow-up, and should therefore receive special attention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828676     DOI: 10.1016/j.jclinepi.2005.11.024

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  31 in total

1.  Establishment, retention, and loss to follow-up in outpatient HIV care.

Authors:  John A Fleishman; Baligh R Yehia; Richard D Moore; P Todd Korthuis; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

Review 2.  HIV care for geographically mobile populations.

Authors:  Barbara S Taylor; L Sergio Garduño; Emily V Reyes; Raziel Valiño; Rita Rojas; Yeycy Donastorg; Karen Brudney; Jennifer Hirsch
Journal:  Mt Sinai J Med       Date:  2011 May-Jun

3.  Comparing different measures of retention in outpatient HIV care.

Authors:  Baligh R Yehia; John A Fleishman; Joshua P Metlay; P Todd Korthuis; Allison L Agwu; Stephen A Berry; Richard D Moore; Kelly A Gebo
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

4.  Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.

Authors:  Margaret T May; Robert S Hogg; Amy C Justice; Bryan E Shepherd; Dominique Costagliola; Bruno Ledergerber; Rodolphe Thiébaut; M John Gill; Ole Kirk; Ard van Sighem; Michael S Saag; Gemma Navarro; Paz Sobrino-Vegas; Fiona Lampe; Suzanne Ingle; Jodie L Guest; Heidi M Crane; Antonella D'Arminio Monforte; Jörg J Vehreschild; Jonathan A C Sterne
Journal:  Int J Epidemiol       Date:  2012-11-12       Impact factor: 7.196

5.  Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).

Authors:  Véronique Joly; Catherine Fagard; Carine Grondin; Diane Descamps; Yazdan Yazdanpanah; Charlotte Charpentier; Nathalie Colin de Verdiere; Sophie Tabuteau; François Raffi; André Cabie; Geneviève Chene; Patrick Yeni
Journal:  Antimicrob Agents Chemother       Date:  2012-11-19       Impact factor: 5.191

6.  Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.

Authors:  S Krishnan; K Wu; M Smurzynski; R J Bosch; C A Benson; A C Collier; M K Klebert; J Feinberg; S L Koletar
Journal:  HIV Clin Trials       Date:  2011 Jul-Aug

7.  Accounting for dropout reason in longitudinal studies with nonignorable dropout.

Authors:  Camille M Moore; Samantha MaWhinney; Jeri E Forster; Nichole E Carlson; Amanda Allshouse; Xinshuo Wang; Jean-Pierre Routy; Brian Conway; Elizabeth Connick
Journal:  Stat Methods Med Res       Date:  2015-06-15       Impact factor: 3.021

Review 8.  HIV outcomes among migrants from low-income and middle-income countries living in high-income countries: a review of recent evidence.

Authors:  Jonathan Ross; Chinazo O Cunningham; David B Hanna
Journal:  Curr Opin Infect Dis       Date:  2018-02       Impact factor: 4.915

9.  Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

Authors:  Emilie Lanoy; Margaret May; Amanda Mocroft; Andrew Phillip; Amy Justice; Geneviève Chêne; Hansjakob Furrer; Timothy Sterling; Antonella D'Arminio Monforte; Lluís Force; John Gill; Ross Harris; Robert S Hogg; Jürgen Rockstroh; Mike Saag; Pavel Khaykin; Frank de Wolf; Jonathan A C Sterne; Dominique Costagliola
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

10.  Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.

Authors:  Ryan P Westergaard; Timothy Hess; Jacquie Astemborski; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.